BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11876 related articles for article (PubMed ID: 10897006)

  • 1. c-MYC and nodular malignant melanoma. A case report.
    Greulich KM; Utikal J; Peter RU; Krähn G
    Cancer; 2000 Jul; 89(1):97-103. PubMed ID: 10897006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
    Parrella P; Caballero OL; Sidransky D; Merbs SL
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
    Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
    Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation.
    Treszl A; Adány R; Rákosy Z; Kardos L; Bégány A; Gilde K; Balázs M
    Cytometry B Clin Cytom; 2004 Jul; 60(1):37-46. PubMed ID: 15221868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of C-MYC as the origin of the homogeneous staining region in ovarian carcinoma detected by micro-FISH.
    Abeysinghe HR; Cedrone E; Tyan T; Xu J; Wang N
    Cancer Genet Cytogenet; 1999 Oct; 114(2):136-43. PubMed ID: 10549271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
    Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
    J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis.
    Rákosy Z; Vízkeleti L; Ecsedi S; Vokó Z; Bégány A; Barok M; Krekk Z; Gallai M; Szentirmay Z; Adány R; Balázs M
    Int J Cancer; 2007 Oct; 121(8):1729-37. PubMed ID: 17594688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma.
    Gerami P; Jewell SS; Pouryazdanparast P; Wayne JD; Haghighat Z; Busam KJ; Rademaker A; Morrison L
    J Mol Diagn; 2011 May; 13(3):352-8. PubMed ID: 21497295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
    van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A
    Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of N-myc oncogene in human melanoma cells.
    Bauer J; Sokol L; Stríbrná J; Kremen M; Krajsová I; Hausner P; Hejnar P
    Neoplasma; 1990; 37(3):233-8. PubMed ID: 2370914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.
    Reiter RE; Sato I; Thomas G; Qian J; Gu Z; Watabe T; Loda M; Jenkins RB
    Genes Chromosomes Cancer; 2000 Jan; 27(1):95-103. PubMed ID: 10564591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma.
    Adsay NV; Dergham ST; Koppitch FC; Dugan MC; Mohamed AN; Vaitkevicius VK; Sarkar FH
    Pancreas; 1999 Mar; 18(2):111-6. PubMed ID: 10090407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma.
    Armengol G; Knuutila S; Lluís F; Capellà G; Miró R; Caballín MR
    Cancer Genet Cytogenet; 2000 Jan; 116(2):133-41. PubMed ID: 10640145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization.
    Glatz-Krieger K; Pache M; Tapia C; Fuchs A; Savic S; Glatz D; Mihatsch M; Meyer P
    Virchows Arch; 2006 Sep; 449(3):328-33. PubMed ID: 16523260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.
    Selvarajah S; Yoshimoto M; Ludkovski O; Park PC; Bayani J; Thorner P; Maire G; Squire JA; Zielenska M
    Cytogenet Genome Res; 2008; 122(1):5-15. PubMed ID: 18931480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
    Minca EC; Tubbs RR; Portier BP; Wang Z; Lanigan C; Aronow ME; Triozzi PL; Singh A; Cook JR; Saunthararajah Y; Plesec TP; Schoenfield L; Cawich V; Sulpizio S; Schultz RA
    Cancer Genet; 2014; 207(7-8):306-15. PubMed ID: 25442074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomic hybridization analysis of hereditary swine cutaneous melanoma revealed loss of the swine 13q36-49 chromosomal region in the nodular melanoma subtype.
    Apiou F; Vincent-Naulleau S; Spatz A; Vielh P; Geffrotin C; Frelat G; Dutrillaux B; Le Chalony C
    Int J Cancer; 2004 Jun; 110(2):232-8. PubMed ID: 15069687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
    Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 594.